Reading Time: 2 minutesDeveloping disease models is important for furthering our understanding of MND and allows researchers to screen potential new drugs for a beneficial effect. Moving a
Category: Treatments
Reading Time: 2 minutesDeposits of the protein TDP-43 are found within the motor neurones in the majority of cases of MND, and are considered a pathological hallmark of
Reading Time: 3 minutesTo mark International Clinical Trials Day (20 May) we reflect on the ALS Clinical Trials Guidelines workshop that took place in March. The MND Association
Reading Time: 4 minutesThe recent announcement about the use of stem cells to treat a form of multiple sclerosis (MS), together with early results from the BrainStorm stem
Reading Time: 5 minutesClinical trials determine if potential treatments are safe and aim to prove beyond reasonable doubt whether a drug is beneficial. They are therefore the gold
Reading Time: 3 minutesBar a few bacteria usually found hitching a ride on our dental plaque and digestive system, every living cell in the human body needs oxygen.
Reading Time: 5 minutesA clinical trial of Jedi proportions… The MND Association is backing a new clinical trial in MND, known as MIROCALS. This will be a joint
Reading Time: 3 minutesThe MND Association’s Director of Research, Brian Dickie explains more about ‘GM6’, also known as ‘GM604’, a drug in development by an American pharmaceutical company
Reading Time: < 1 minute“On the fourth day of Christmas MND research gives to you… on the FOURTH month of 2014, we announced that we’ll fund an exciting new